CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,100 enrolled
Drug / intervention
START +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02776254
NCT02776254N/ACompleted
CompareCT.gov

Community ART for Retention in Zambia: Evaluating the Feasibility, Effectiveness, and Efficiency of Decentralized and Streamlined Antiretroviral Therapy Care Models

Centre for Infectious Disease Research in Zambia·interventional·Posted May 18, 2016·Updated Feb 8, 2019

In Brief

A clinical study evaluating START, CAG, and 2 other interventions for HIV. Completed, enrolled 3,100 participants across 1 site.

Detailed Summary

This study seeks to create generalizable knowledge about the implementation process as well as the effectiveness and efficiency of a differentiated care system, by measuring patient health outcomes and implementation outcomes such as acceptability, feasibility, fidelity, and costs

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV
CountriesZambia
CollaboratorsJohns Hopkins University, University of Alabama at Birmingham, University of California, San Francisco, American Institutes for Research, University of Zambia, Ministry of Health, Zambia, Johns Hopkins Bloomberg School of Public Health

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 18, 2016
Enrollment StartMar 1, 2016
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.1 years ago

Interventions

STARTother

Point of care testing for rapid ART initiation

CAGother

Community Adherence Group

UAGother

Urban Adherence Group

FAST-TRACKother

Prescription refill only